1. Home
  2. RCMT vs RNAC Comparison

RCMT vs RNAC Comparison

Compare RCMT & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$27.50

Market Cap

140.8M

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$6.12

Market Cap

161.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCMT
RNAC
Founded
1971
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.8M
161.2M
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
RCMT
RNAC
Price
$27.50
$6.12
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$35.00
AVG Volume (30 Days)
60.1K
132.4K
Earning Date
04-03-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
27.38
N/A
EPS
2.14
N/A
Revenue
$186,737,000.00
$2,797,000.00
Revenue This Year
$16.29
N/A
Revenue Next Year
$6.92
N/A
P/E Ratio
$12.73
N/A
Revenue Growth
5.83
N/A
52 Week Low
$15.29
$5.60
52 Week High
$28.19
$14.56

Technical Indicators

Market Signals
Indicator
RCMT
RNAC
Relative Strength Index (RSI) 82.25 41.47
Support Level $26.23 $5.89
Resistance Level N/A $7.81
Average True Range (ATR) 1.34 0.41
MACD 0.98 -0.01
Stochastic Oscillator 96.68 41.80

Price Performance

Historical Comparison
RCMT
RNAC

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: